This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Clinical & Medical Affairs
Clinical trials

Survey: Point of Care Testing in Clinical Trials 2021

Posted by on 14 October 2021
Share this article

Point of Care Testing - laboratory diagnostic testing conducted at investigator sites or at a subject’s home – has the potential to transform clinical trials, offering immediate results, even at a patient’s home. However, a number of barriers still exist to implementation, ranging from cost, to accuracy, to regulatory issues.

Clinical Trials Europe is conducting a huge survey across clinical trials professionals around the world on Point of Care Testing in clinical trials. The final report will reveal unique insights into the current adoption of Point of Care Testing, the challenges around it and how it is likely to change in the coming years. Completing the survey will take just 5 minutes and will give you exclusive early access to the final report. All answers will remain anonymous.

We’re excited to see the results of this unique study and we hope you are too.

Complete the survey here.

Share this article